Pathologic changes in brain tissue during and after stroke may lead to injury of the blood-brain barrier (BBB) and subsequent hemorrhagic transformation (HT). In a rat model of HT, the apparent diffusion coefficient of water, cerebral blood flow, relaxation times, T 1 and T 2 , and magnetization transfer (MT) related parameters (T 1sat , K for and the MT ratio) were repetitively measured during 3 h of focal ischemia and 2 h of reperfusion (n ؍ 8). Areas of BBB opening were identified by sequential assay of the transcapillary influx of Gd-diethylenetriaminepentaacetic acid (Gd-DTPA) by MRI and 14 C-␣-aminoisobutyric acid (AIB) by quantitative autoradiography. Ischemia-injured regions of interest were identified from the MRI data and divided into those with and without BBB opening. Of the several MRI parameters measured, the T 1sat in the caudate-putamen and preoptic area during ischemia and the first 2 h of reperfusion correlated best with the regional pattern of BBB opening observed thereafter. These data suggest that an ipsilateral/ contralateral T 1sat ratio > 1.6 demarcates leakage of small molecules such as Gd-DTPA and AIB across the BBB. Key words: Gd-DTPA; hemorrhagic transformation; magnetization transfer; MRI; rt-PA; stroke Thrombolysis using recombinant tissue plasminogen activator (rt-PA) has proven to be an effective intervention for the treatment of acute ischemic stroke (1), but the risk of hemorrhagic transformation (HT) following such treatment remains an obstacle to widespread usage of thrombolytic agents. To illustrate this risk, the probability of symptomatic HT increases significantly during the first 36 h after stroke onset in patients receiving rt-PA (6.4% vs. 0.6% in placebo-treated patients), and 61% of the patients with symptomatic HT die within 3 months (1). Studies performed using animal stroke models show similar findings with increased risk of HT associated with thrombolytics (2-5). In view of these complications with thrombolytic therapy, it is important to develop diagnostic imaging techniques that reliably identify tissue regions that are prone to HT and to obtain such data when deciding on a treatment protocol.One of the possible imaging techniques is computed tomography (CT). The sensitivity of CT for detection of early ischemic damage remains controversial because a significant proportion of stroke patients show negative acute CT images but go on to develop large infarcts (6). Although it is the standard diagnostic test for extant cerebral bleeding, CT has a limited capacity to predict HT in ischemic stroke (7). An early report from the NINDS rt-PA Stroke Trial showed only a 57% efficiency for the prediction of symptomatic HT based on early CT findings (1). A more recent retrospective analysis of CT films from the trial adjusted the data for group imbalances in several baseline clinical features and found that early ischemic changes were not predictive of clinical deterioration at 24 h or of symptomatic intracerebral hemorrhage (i.e., death) at 90 days (8). It may be that high...